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ABSTRACT AND KEYWORDS PAGE 
 
a. Full Title 
The positioning of palliative care in acute care: A multi perspective qualitative study in the 
context of metastatic melanoma 
 
b. Abstract 
Objective: The positioning and meaning of palliative care within the health system lacks 
clarity which adds a level of complexity to the process of transition to palliative care. This 
study explores the transition to palliative care process in the acute care context of metastatic 
melanoma. 
Method: A theoretical framework drawing on interpretive and critical traditions informs the 
research. The pragmatism of symbolic interactionism and the critical theory of Habermas 
brought a broad orientation to the research. The integration of the theoretical framework and 
grounded theory methods facilitated data generation and analysis of 29 interviews with 
patients, family carers and health professionals. 
Results: The key analytical findings depict a scope of palliative care that was uncertain for 
users of the system and for those working within the system. Becoming ‘palliative’ is not a 
defined event and nor is there unanimity around referral to a palliative care service. As such, 
ambiguity and tension contributed to difficulties in negotiating the transition to palliative care. 
Significance of Results: The findings point to uncertainty around scopes of practice in the 
transition to palliative care. The challenge in the transition process lies in achieving greater 
coherency in care within an increasingly specialised health care system. The findings may not 
only inform those within a metastatic melanoma context but may contribute more broadly to 
palliative practices within the acute care setting. 
 
KEYWORDS: Palliative, Acute, Specialisation, Melanoma, Transition  
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INTRODUCTION 
In recent years palliative care has become an important component of the cancer 
trajectory with a number of studies identifying the benefits of early referral to this form of 
care (Bakitas, et al., 2009; Higginson & Evans, 2010; Temel et al, 2010; Zimmerman et al., 
2014). Nonetheless, the transition to palliative care is often poorly negotiated and health 
professionals face substantial challenges in determining the appropriate time for referral 
(Johnson et al., 2011a; Broom, Kirby, Good, Wootton & Adams, 2012; Wentlandt et al., 
2012; Ramchandran & von Roenn, 2013). Hence, while there has been significant growth of 
palliative care services, the extent of use of this specialty service varies considerably (Hardy, 
Maresco-Pennisi, Gilshenan & Yates, 2008; Johnson et al, 2008; Campbell et al., 2010; 
Wentlandt et al., 2012). To date there has been little in-depth exploration of factors that 
influence the positioning of palliative care in the acute care sector.  
 
Although palliative care is relevant to all disease types, the development of a relationship 
between palliation and oncology underpins the current position of palliative care. In the 
1950s, all treatments for advanced cancer were very much palliative and while treatments 
made it possible to prolong the lives of patients there were questions around the point at 
which these treatments should cease. Two opposing views evolved in the treatment of cancer, 
one where death was seen as a largely natural process that ended pain and suffering and the 
other where death was something to be resisted with medical intervention. As Rynearson 
(1959) wrote at the time: 
Despite all the impressive ministrations science can provide, he [sic] [the 
patient] is still dying and is still suffering. There simply is no other 
treatment to apply now, for there is no treatment for death. (p. 85). 
 
As new chemical treatments were developed that temporarily halted or slowed the growth 
of some forms of cancer, issues around ongoing treatment arose more frequently and 
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personal, medical and research interests became more intertwined. It was suggested that 
successful treatments could only come from doctors who do too much when the odds appear 
overwhelming rather than those who do too little (Karnofsky, 1960). Thus ongoing aggressive 
treatment avoided the defeatism that was perceived a major barrier to the advancement of 
medical knowledge (Karnofsky, 1962). This approach was associated with the appearance of 
a culture of experimentation and clinical trials that saw the establishment of medical oncology 
as a specialty in the US in 1973, the formation of the European Society of Medical 
Oncologists in 1975 and the establishment of the Medical Oncological Group of Australia in 
1977 (Casali, 2011; Baszanger, 2012; Medical Oncology Group of Australia, 2013). 
 
By the 1970s and 1980s, a cure for cancer was deemed possible which gave rise to the 
public rhetoric of scientific progress and an imminent cure. As a result, the issue of treatment 
withdrawal was put aside (Holleb, 1972). Where cancer was constructed as a disease that 
could be controlled, death was constructed as the enemy and symbolic of failure (Baszanger, 
2012). Yet, such views prompted recognition of the need for an alternative for those dying 
patients for whom physicians could do no more and for those dying in a highly medicalised 
and treatment focused environment (Clark, 2007). Palliation of impending death was left to 
those working within the philosophy and practice of palliative care and the issue was then the 
point at which definitive treatment of a patient with advanced cancer be stopped and the 
patient referred to hospice or palliative care (Potter, 1980). Yet oncologists such as Krakoff 
(1979) expressed the concern that:  
In our rush to provide for the dying, we may neglect those who may not be 
quite ready to die…in seeking “death with dignity” we may overlook 
treatable disease and provide patients with the indignity of premature death. 
(p. 108–109) 
 
Ethical and moral issues were at play but so too were the boundaries and mandate of 
oncology (Baszanger, 2012). This issue is evident today where ongoing advances in therapies 
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and the redefining of cancer as a chronic disease have blurred boundaries between active 
treatment and terminal phases. While “to palliate” means “to make (a disease or its 
symptoms) less severe without removing the cause” (Oxford Dictionaries, 2013), in the world 
of cancer care “to palliate” means something more complex than this definition implies. 
When it is used in the context of palliative care it may be understood as a philosophy of care, 
an institution of care, or a service provided by a group of health professionals with specific 
knowledge and expertise. 
 
This paper presents findings from the first author’s doctoral research that explored how 
the concept of transition to palliative care was constructed and negotiated in the acute care 
setting of metastatic melanoma. Melanoma is a form of skin cancer and is one of the most 
aggressive of human malignancies. In Australia, in 2012, 1,515 people died from melanoma 
(Australian Government, 2014). The incidence of melanoma in this country is increasing 
more rapidly than that of any other cancer and it is predicted that by 2020 it will be the third 
most commonly diagnosed cancer in Australia (Australian Institute of Health and Welfare 
(AIHW), 2012). When detected early and the disease is superficial melanoma has a five-year 
relative survival rate of 95% (AIHW, 2010); however this rate falls to below 10% for 
metastatic disease with the median survival being less than 12 months (Hodi et al., 2010; 
Thompson, Scolyer, & Kefford, 2009). 
 
The Clinical Practice Guidelines for the Management of Melanoma in Australia and New 
Zealand recognises that palliative care referrals are appropriate at any stage of illness and 
recommends that “referral for palliative care be based on the needs of the patient and family, 
not just the stage of disease” (Australian Cancer Network Melanoma Guidelines Revision 
Working Party, 2008). Despite these recommendations many cancer clinics and oncologists 
have not incorporated these standards into routine practice and this has implications for timely 
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referrals (Hui et al., 2010; Broom Kirby, Good, Wootton, & Adams, 2012; Wentlandt et al., 
2012). This research applied a critical lens to the transition to palliative care process to 
generate insight into the relationship between the positioning and practice of palliative care in 
the acute care context of metastatic melanoma. The paper focuses on the lack of clarity 
around the meaning of palliative care and confusion around its role within the acute health 
care system. Other aspects of the findings of the study will be reported elsewhere. 
 
METHOD 
Study Design and Theoretical Framework 
The research drew on interpretive and critical knowledge informed by the works of Mead, 
Blumer and Habermas. The pragmatism of symbolic interactionism (Mead, 1934; Blumer, 
1969) and the critical theory of Habermas (1984, 1987) provided a broad orientation that gave 
focus to both the micro level of interpretation and the structural level within which the 
transition to palliative care was constructed and negotiated. The Mead and Blumer focus on 
the dynamics of interaction provided insight into the ways in which meanings were 
constructed. In extending this framework, Habermas’ concepts of system and lifeworld were 
germane where the system represents technical scientific rationality and the lifeworld denotes 
the everyday world that humans share with others. Hence, these latter ideas extended the 
analysis from human action to the systemic and structural levels. The critical theoretical frame 
also countered any tendency for an over-reliance on the words of participants at the expense 
of examining the whole of which they were a part (Alvesson & Sköldberg, 2009). 
 
The methods were drawn from the interpretive works of Glaser and Strauss (1967) and 
Charmaz (2006, 2009, 2011a, 2011b). Although traditionally associated with symbolic 
interactionism, the methods align with the approach adopted in this research. The theoretical 
frame recognises the researcher’s active role in shaping data and analysis and the constraints 
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that historical, social and situational conditions impose upon actions (Charmaz, 2011a). 
Grounded theory methods have also become generalised, reconstructed and contested and as 
Charmaz (2011b) has acknowledged, can be used in flexible ways. The flexibility of the 
methods allowed for multiple perspectives to be explored, alternative interpretations to be 
generated and the analysis of these within the context of broader structures. The result was a 
critical understanding rather than a simple description of the experience. 
 
Participants 
Patients and family carers were recruited through a major public hospital in Queensland, 
Australia and from a melanoma advocacy and support group. Health professionals were 
recruited through the same public hospital. The hospital has a specialist melanoma clinic and 
a consulting palliative care service. Ethical clearance to conduct the study was obtained from 
the Human Research Ethics Committees of the major public hospital and the Queensland 
University of Technology.  
 
In recruiting patients it was recognised that there were unique challenges with the 
research as patients may have been unwell, emotionally fragile and fatigued (White & Hardy, 
2010). While the researcher was cognisant of this issue patients were willing to participate. 
Those taking part perceived that the interviews allowed them to make a contribution to 
society and articulated the benefit of voicing concerns. 
 
Patient participants had been diagnosed with metastatic melanoma and at the time of 
interview half of those recruited had been referred to palliative care. The total sample 
consisted of eight patients, eight family carers and 13 health professionals. The age 
distribution of patient participants was 21-30 years (n=1); 31-40 years (n=3); 51-60 years 
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(n=2); and 61-70 years (n=2). Six patient participants were male. The median time from 
diagnosis of metastatic melanoma to interview was seven months (range 1-72 months). 
 
Of the eight family carers interviewed, seven were patients’ spouses and one was a 
patient’s daughter. Patients and carers were interviewed separately. Health professional 
participants comprised consultants, registrars, nurses and allied health professionals. Of these, 
eight were from cancer services (hereafter referred to as non-palliative care health 
professionals) and five were from palliative care services (hereafter referred to as palliative 
care health professionals). 
 
Data Collection 
Data were generated through semi-structured interviews. On average patient interviews 
were of 64 minutes duration (range 31-88 minutes), while carer interviews averaged 68 
minutes (range 37-108 minutes). Interviews with health professionals averaged 50 minutes 
(range 35-70 minutes). Interviews were audio recorded and transcribed verbatim. Interview 
questions were broadly posed, for example: Tell me of your experience with metastatic 
melanoma. The initial interviews were largely unstructured to allow for full exploration of the 
study phenomenon. 
 
Data Analysis 
Following the completion of each interview, noteworthy events and initial analytical 
thoughts and reflections were memoed. The disaggregation and analysis of data was 
accomplished through initial and focused coding. The constant comparative method was also 
used to shift the analysis from the empirical to the theoretical level (Glaser, 1978; Charmaz, 
2006). During this phase a critical lens was applied to explore implicit meanings and actions 
and to thus identify directions to pursue. The first author questioned tacit assumptions, 
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explicated actions and meanings, compared data with data, and identified gaps in the data 
(Charmaz, 2006). In addition, the first author’s supervisors reviewed the data in order to 
discuss potential concepts and processes that informed subsequent data collection and 
analysis. This latter process was not for validation purposes but rather to extend the analytical 
conversation, encourage further reflexivity, and promote deeper analysis. 
 
FINDINGS 
A significant insight of the phenomenon studied was the way in which palliative care was 
constructed and positioned in the acute care setting. A starting theoretical premise was that 
the construction of meaning is negotiated through an ongoing interpretive process that occurs 
during interactions and over a period of time (Blumer, 1969). As such it was necessary to first 
interpret the meanings ascribed to palliative care. This included exploring what it meant to be 
referred to palliative care. Thus the construction and positioning of palliative care reflected 
the histories, cultures and experiences of participants rather than an objective truth that sat 
apart from participants. 
 
Constructing palliative care 
Managing physical symptoms 
The meaning assigned to palliative care by patient participants was more often focused on 
physical care with little or no reference to the psychosocial and spiritual dimensions. This 
contrasts with the generally accepted association between palliative and holistic care. More 
specifically, the expertise of the palliative care team in the acute sector was conceived of in 
terms of technical strategies for symptom relief. Patient and family carers equated palliative 
care with treatment such as medication for pain: 
Pain relief has probably been the main thing that they have done for me, 
that I think is a main part of palliative care…pain management. Patient H05 
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I think palliative care; my interpretation is controlling pain, not really 
doing medical procedures, but making you as comfortable as possible to the 
end I guess. Patient G05 
 
Thus, in the hierarchy of care, medical intervention appeared more prominent than the 
psychological, social or spiritual components as described by another participant: 
Palliative care has so far been more concerned, and I don’t know, maybe 
this is their sole role, but they seem to be more concerned about John’s 
(husband pseudonym) symptoms and ensuring that he has medications to 
alleviate that. No one has really spoken to us about any other support 
services. Carer H04 
 
A palliative care nurse posed palliative practice as philosophically concerned with care 
beyond management of physical symptoms: 
In palliative care you learn that quality of life is more important or we're 
more about quality of life than quantity, whereas I think a lot of people who 
go into nursing and medicine have that view of ‘life at any cost’. I know 
that's what was instilled in me when I was training as a nurse, that any kind 
of life is better than death and it's a completely different shift in 
consciousness and awareness when you start doing palliative care. It's just 
a different approach I guess. Palliative care health professional 06 
 
Yet an oncologist was reluctant to refer to palliative care in the absence of symptoms: 
When they come to us for the most part it is palliative; palliative 
chemotherapy because people with stage four melanoma are not curative… 
There are a lot of patients who actually don’t want to hear palliative care 
and no matter what some of my palliative care colleagues think, there are 
patients who do not want to see them and it’s very hard to force someone to 
meet someone they don’t want to see and especially if they’ve got no 
symptoms. Non-palliative care health professional 12 
 
The approach depicted above underlines the ambiguity and tension in the construction of 
palliative care. Where some described a role that included the emotional and physical aspects 
of care, for others, palliative care was predominately about physical concerns. 
 
Managing end of life 
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The role of palliative care was recognised by patients, carers and health professionals as 
confined to the management of end-of-life issues. It was about what could be done when there 
were no options. It was overtly associated with end-of-life care. Patients and family carers 
sustained this view as a family carer noted: 
I guess my understanding of palliative care was that they were mostly about 
end-of-life care and that they were more about providing medications to 
alleviate symptoms… and that it was more the very end of life type thing. 
Carer H04 
 
Another patient expressed similarly: 
Palliative means there is no formal medical treatment that is available to 
you. So you are just really living with the disease. It is a matter of 
ameliorating all the things, the consequences of it, in a sense, making life 
bearable… You are at the last stage of your journey, the really last stage of 
your journey. Patient G06 
 
The palliative care health professional participants reinforced the view that this form of care 
signified the end as indicated in the following: 
I think people… feel like they're being given a choice between life and death 
really. It's not good death versus bad death; life equals pursuing treatments 
and saying yes to whatever is offered and dying is accepting palliative care. 
Palliative care health professional 09 
 
Oncologists and those in the treating team also made reference to a reluctance to refer 
because of an association with end-of-life care: 
It's hard because people have this mentality [that] palliative care means it's 
the end of life… so when you actually start talking to a patient about their 
treatments and say, “we're going to get you to see palliative care”, all of a 
sudden they've got the message, well I'm going to die. Non-palliative care 
health professional 03 
 
Even where an oncologist acknowledged the benefits of palliative care there was an implicit 
assumption that such care was end-of-life: 
There's always an initial concern about the word palliative care meaning 
that the patient is on their way out and I try to always defuse that and say, 
well, look no I'm not sending you on a road to your grave. I'm sending you 
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to see someone who can help you and improve your quality of life during the 
terminal stages of your disease. Non-palliative care health professional 01 
 
Health professionals may recognise the benefits of palliative care but reinforce the belief that 
such care means nearing the end. This positions palliative care in the later stages of the 
disease trajectory where treatment is no longer impacting on disease progression. 
 
Referral to palliative care 
 A palliative care referral was associated with a number of antecedents. These included 
the preparedness of patient and family, the readiness of health professional to refer and the 
ability of the health system to respond. 
 
Patient and family preparedness 
Palliative care was often associated with more serious disease progression: 
We were set up with a palliative care team, pretty much straight away, so I 
guess that was part of, I guess knowing early on, that something was going 
to happen. I am guessing they don’t do that type of thing unless it is that 
serious. Patient H03 
 
There was an acknowledgement of the benefits of an earlier referral to palliative care and yet 
also apprehension or fear around the implications of such a referral as noted by one carer: 
You don’t want to be needing them when you are on death’s door, so how 
early is too early to meet palliative care. So it’s a hard thing to try and 
balance, you don’t want to scare people, but you don’t want them to find out 
too late either. Carer G03 
 
As such, although the benefits of palliative care may be recognised by patients, carers and 
health professionals, in some instances the referral is delayed until the patient and family are 
deemed ‘ready’ for referral. 
 
Health professional readiness to refer 
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Palliative care is a referral dependent specialty and oncologists are therefore the 
gatekeepers in the transition process. Oncologists tend to refer late and often at a time of crisis 
as indicated by a health professional: 
I think sometimes there is a little bit of reluctance on the part of the 
oncologist to refer to palliative care because they still see the patient in 
active treatment even though they may be deteriorating and not managing 
well with the treatment and because of that will not refer them until crisis 
time. Non-palliative care health professional 08 
 
A further complexity in the referral process is the perception of oncologists that they have the 
expert knowledge required to manage the needs of patients: 
There would be a lot of oncologists that won't refer on to palliative care, 
they will just hold onto patients… They see themselves as physicians and 
that they can manage all of the patient's needs even though they're probably 
overworked, have too many patients on treatment… and probably can't 
really attend to those patient's specific needs. Non-palliative care health 
professional 08 
 
Referral between specialisations thus was also an issue for health professionals: 
There are political issues involved in referring patients from one 
professional to another. I personally don't have a problem with it but there 
are some other colleagues… who do have problems with that issue. Non-
palliative care health professional 01 
 
The interrelationship of specialized knowledge and the physical location of specialties was a 
significant factor in the transition to palliative care process.  
  
Health system’s ability to respond 
The organisation of a physical separation of oncology and palliative care services 
impacted the way in which palliative care was able to respond as evident in the following 
excerpt: 
So oncology is on the ground floor and second floor, it's all together. Then 
the palliative care office is on the fifth floor tucked away from everybody 
and everything. I mean that in itself speaks volumes to me of the perception 
that palliative care owns that little office upstairs on the fifth floor away 
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from everybody. It is nowhere near the oncology services … it would make a 
lot of sense to have palliative care working side by side with oncology, 
within the oncology department. Palliative care health professional 09 
 
The physical separation of palliative care from oncology, although unsatisfactory from a 
palliative care service perspective, might be appropriate for an oncology unit with a focus on 
clinical trials as implied in the following: 
The nature of melanoma patients I've seen in the last couple of years is that 
they are on these trials… so the oncologist is the main person in charge. I'm 
not saying that they don't give a referral to palliative care but I think, not all 
oncologists but some, really dig their heels in and don't refer as early as 
they could. Non-palliative care health professional 04 
 
Comprehensive coordination and planning to address physical, emotional and spiritual 
aspects of care takes time. As noted in the following excerpts time constraints were an issue 
for oncologists: 
I (oncologist) guess a lot of palliative care is actually having the time to sit 
down with the patients and I certainly don't have that time to sit down with 
patients and I know the medical oncologists don't. Non-palliative care health 
professional 08 
 
Dr P (oncologist) has said to Dr N (palliative care consultant) "we haven't 
got time to talk about decisions, we just make them". They (oncologists) 
have not got time. They've got so many people coming through those clinics. 
Palliative care health professional 11 
 
While referral to a palliative care physician may be a more effective use of an organisation’s 
workforce the timing of a referral in this research remained an issue. Where oncologists were 
gatekeepers of referrals, conflicts of interest arose because of the complex professional, 
cultural and social issues noted above. 
 
Positioning palliative care 
The lack of clarity around the meaning of palliative care and the differing interpretations 
of the scope of this care was evident in an absence of consensus among professional groups 
	 15
on the positioning of palliative care in the acute care setting. A treating clinician pointed to 
the complexity of referral to palliative care: 
So I think referral to palliative care is based on not just the patient or their 
tumour characteristics, but on their treating physician and where they're 
being treated. It's a pretty complex number of issues that need to come 
together for that referral to take place. Non-palliative care health 
professional 08 
 
The treating team struggled with referral to the service even though palliative care was 
considered an important phase in the disease trajectory. This was evident in the words of a 
treating clinician: 
Once it reaches the phase of palliative care any other role I have is 
supportive and typically when I have my own patients that reach that point 
it's not unusual for me to keep seeing the patients as almost a social visit. 
It’s as if I cut ties with them the patient sees "well that's it. That's the end of 
it all". Non-palliative care health professional 13 
 
This in turn highlights the complexity around the positioning of palliative care as a 
medical specialty. Health professionals, including treating clinicians, may provide a palliative 
approach to care with referral to a specialist palliative care service dependent upon the 
judgment of individual clinicians. As such, not only do boundaries exist between palliative 
medicine and other medical specialties, but also between palliative medicine and a palliative 
approach to care. 
 
DISCUSSION 
The positioning of palliative care was a salient concept in the research findings. 
Becoming ‘palliative’ is not a defined event and nor is there certainty around referral to a 
palliative care service and yet it is a referral dependent specialty (Tieman et al., 2009). 
Furthermore, research concludes that much of the care offered to dying patients in acute care 
settings is routine and technological care, rather than individualised and contextual 
(Pincombe, Brown & McCutcheon, 2003; Parish et al., 2006; Willard & Luker, 2006; 
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Johnson, Paul, Girgis, Adams & Currow, 2011b). This is reinforced by Breitbart (2006) who 
asked palliative care clinicians what they saw as their goals. As Breitbart (2006) wrote: 
The response was immediate, simple, clear, and emphatic. Overwhelmingly 
the palliative care clinicians saw their main goal and obligation as assuring 
that the patients under their care die receiving adequate pain and symptom 
control. Nothing more, nothing less. (p. 2) 
 
When Breitbart (2006) posed questions to the clinicians about existential concerns and 
helping patients achieve a sense of life completion and acceptance of death the response was, 
“That’s not our job!” (p. 2). This was the work of the clergy. In some sense this response 
reflects the broad domain of palliative care. It also points to the limitations imposed by 
specialisation and the technical medical agenda within the acute care setting. Against this 
background, palliative care has largely been constructed as technical expertise in symptom 
management that in turn is equated with quality of life in end-of-life care. 
 
Indeed, in this situation and using Habermas’s (1984) terminology, the technical scientific 
rationality of the system dominates while the patient’s lifeworld is of lesser concern. The 
lifeworld signifies the knowledge and way of life of patients and is based on communication, 
agreement and consensus (Habermas, 1984). Palliative care arose from the hospice movement 
that was situated in the lifeworld and was established in response to what was considered 
neglect for care of the dying. The philosophy of hospice care and subsequently palliative care 
includes the goals of enhancing quality of life, optimising function, helping with decision-
making and providing opportunities for personal growth (Ferrell & Grant, 2014).  
 
The above goals do not readily translate into the acute care setting. This setting rests on a 
body of expert medical knowledge that has been shaped by science and technology and 
strongly influenced by a system where an instrumental focus on successful treatment and an 
orientation towards the control of biological process dominates (Barry et al., 2001). Thus, the 
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difficulty in positioning palliative care reflects the tension between the institutionalisation of 
palliative care in the acute setting and the development of palliative care from its origins 
situated outside mainstream medicine.  
 
Furthermore, there is decisional and clinical ambiguity because there is no predefined 
point in the course of a life limiting illness that marks the transition from curative to palliative 
care. A patient’s clinical situation and psychological readiness, a health professional’s 
knowledge, understanding, attitudes and preparedness and a system’s ability to respond all 
form part of the complex construction of palliative care. The result is levels of uncertainty and 
differing and contradictory perspectives that characterise the transition to palliative care. 
 
On a daily basis oncologists interact with patients who may benefit from a referral to 
palliative care and indeed there is the opportunity for earlier referral. As such, oncologists 
play a significant role in shaping the meaning of palliative care. Yet, despite a tendency for 
oncologists to agree that early referral to palliative care is desirable, studies consistently show 
that patients are referred late (Johnson et al., 2008; Wentlandt, et al., 2012; Hannon & 
Zimmermann, 2013).  
 
Most patients are referred within 30 to 60 days prior to death and with many in the last 
days of life (Wentlandt et al., 2012). Furthermore, oncologists are reluctant to relinquish any 
aspect of care even where treatment is described as palliative. This may, in part, be a result of 
the curative culture of the hospital environment and the deeply embedded mission of 
physicians to heal patients (Horowitz et al., 2014). A generalised discomfort with death and 
dying and a concern by physicians that frank discussions of prognosis could reduce patient 
hope may also influence a late referral (Howie & Peppercorn, 2013). 
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Ideological, clinical, professional and practical issues thus perpetuate the dichotomy 
between guidelines supporting early palliative care referral and the reality of clinical practice 
(Hannon & Zimmerman, 2013). While referral to palliative care can offer patients the 
opportunity to define their goals and expectations for ongoing care this may also mean 
confronting the limitations of medical treatment and the reality that life is finite (Wright et al., 
2008). The perception of palliative care as end-of-life care constructs cancer care as 
dichotomous; that is cure versus care. Health professionals may perceive discussion of end-
of-life issues or referral to palliative care as an admission of failure to cure (Yabroff, 
Mandelblatt & Ingham, 2004).  
 
As noted earlier, palliative care evolved out of the hospice movement. This development 
saw palliative care positioned on the periphery of mainstream health care. Proponents of 
palliative care sought to address this marginalisation with the recognition of palliative care as 
a medical specialty. The result has been an increasingly porous boundary between the two 
areas and at the same time greater ambiguity and uncertainty (Arber, 2007; Meghani, 2004). 
 
In addressing the complexities around the positioning of palliative care there is a 
distinction between a palliative approach to be provided by all health professionals and 
palliative care that includes specialist palliative care providers. As Hibbert et al. (2003) note, 
the difficulty is in identifying where regular care ends and palliative care begins and this 
concept underscores the separateness of palliative care from everyday medical practice. 
Where a ‘generalist’ role is actively promoted positioning the expertise of palliative medicine 
and palliative care becomes problematic (Hibbert et al., 2003). The issue then is whether 
palliative care should be a part of the role of a medical specialist or integral to the roles of all 
health professionals. 
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Modern medicine has evolved to a point where scientific expertise and the instrumental 
technical system dominate to the extent that the communicative practices that are essential in 
everyday life are often absent from the medical encounter. Habermas (1987, p. 395) suggests 
that social conflicts “arise along the seams between system and lifeworld”. It is within this 
space that palliative care tenuously sits and boundaries are drawn between the technical 
system and the communicative practices of the lifeworld. Indeed, the colonisation of the 
lifeworld has seen palliative care move from everyday life to a position where it is 
administered through healthcare institutions and the lens of expert medical science.  
 
CONCLUSION 
Palliative care is a modern specialty that seeks to be defined in terms of the healthcare 
continuum. Although palliative care is perceived as a specialty and part of a multi-disciplinary 
approach at the early stage of care of a patient with terminal illness, the difficulty lies in 
negotiating the transition to palliative care. Diverse philosophical views of health care and a 
hierarchy of knowledge underpinned by specialisation generate tensions and the expected 
seamless continuum of care through the disease trajectory does not exist. 
 
There is no definitive position for palliative care in a metastatic melanoma disease 
trajectory. The different perspectives of patients, carers and health professional groups add 
complexity to the transition to palliative care. The implication for patients and families is an 
experience of uncertainty and confusion in negotiating the health system. The challenge in the 
transition process lies in achieving greater coherency in care within an increasingly 
specialised health care system.  
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A strength of the study is that it drew on the experiences of a diverse group of 
stakeholders to generate insight into the complexity of the process of transition to palliative 
care. Although the setting of a single site for recruitment made the study feasible in terms of 
resources and time, this may be considered a limitation of the study. However, the purpose of 
the study was not to generalise but rather to generate insight into the practices and 
understandings around the construction and positioning of palliative care. Thus while the 
findings from this research may not be an exact fit with other sites, it is likely that there will 
be understandings and theoretical insights that resonate across other healthcare settings and 
other cancer-site-specific cohorts. Research within other settings would extend the 
understanding developed here. 
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